Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$191.51 - $216.16 $2.16 Million - $2.44 Million
11,300 New
11,300 $2.4 Million
Q2 2021

Aug 13, 2021

SELL
$135.08 - $161.1 $1.01 Million - $1.21 Million
-7,500 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$137.51 - $190.8 $1.03 Million - $1.43 Million
7,500 New
7,500 $56,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.